{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:15:47Z","timestamp":1793650547417,"version":"4.5.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,16]],"date-time":"2027-02-16T00:00:00Z","timestamp":1802736000000},"content-version":"am","delay-in-days":352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30 DK56338"],"award-info":[{"award-number":["P30 DK56338"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"National Cancer Institute Division of Cancer Prevention","doi-asserted-by":"publisher","award":["U24 CA230144"],"award-info":[{"award-number":["U24 CA230144"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"National Cancer Institute Division of Cancer Prevention","doi-asserted-by":"publisher","award":["P01 CA263025"],"award-info":[{"award-number":["P01 CA263025"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"National Cancer Institute Division of Cancer Prevention","doi-asserted-by":"publisher","award":["R01 CA230503"],"award-info":[{"award-number":["R01 CA230503"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"National Cancer Institute Division of Cancer Prevention","doi-asserted-by":"publisher","award":["U01 CA230997"],"award-info":[{"award-number":["U01 CA230997"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"National Cancer Institute Division of Cancer Prevention","doi-asserted-by":"publisher","award":["R01 CA190776"],"award-info":[{"award-number":["R01 CA190776"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP220119"],"award-info":[{"award-number":["RP220119"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP150587"],"award-info":[{"award-number":["RP150587"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jhep.2025.09.023","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T07:55:47Z","timestamp":1759391747000},"page":"578-586","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["HES V2.0 validation and performance compared to GALAD and ASAP in the HEDS cohort"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5964-7579","authenticated-orcid":false,"given":"Hashem B.","family":"El-Serag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4516-8088","authenticated-orcid":false,"given":"Camden","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Luster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4898-7778","authenticated-orcid":false,"given":"K. Rajender","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neehar","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit G.","family":"Singal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge A.","family":"Marrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0084-5308","authenticated-orcid":false,"given":"Aaron P.","family":"Thrift","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagpreet","family":"Chhatwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziding","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Page-Lester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6388-5123","authenticated-orcid":false,"given":"Qingchun","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6088-167X","authenticated-orcid":false,"given":"Nabihah","family":"Tayob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fasiha","family":"Kanwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2025.09.023_bib1","article-title":"Epidemiology of hepatocellular carcinoma","author":"McGlynn","year":"2020","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jhep.2025.09.023_bib2","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jhep.2025.09.023_bib3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.09.023_bib4","article-title":"Doylestown plus and GALAD demonstrate high sensitivity for HCC detection in patients with cirrhosis","author":"Singal","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jhep.2025.09.023_bib5","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.cgh.2019.11.012","article-title":"GALAD score detects early hepatocellular carcinoma in an international cohort of patients with nonalcoholic steatohepatitis","volume":"18","author":"Best","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.jhep.2025.09.023_bib6","first-page":"1296","article-title":"The GALAD scoring algorithm based on AFP, AFP-L3, and DCP significantly improves detection of BCLC early stage hepatocellular carcinoma","volume":"54","author":"Best","year":"2016","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.jhep.2025.09.023_bib7","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.cgh.2015.12.042","article-title":"Role of the GALAD and BALAD-2 serologic models in diagnosis of hepatocellular carcinoma and prediction of survival in patients","volume":"14","author":"Berhane","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.09.023_bib8","article-title":"A phase 3 biomarker validation of GALAD for the detection of hepatocellular carcinoma in cirrhosis","author":"Marsh","year":"2024","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jhep.2025.09.023_bib9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12014-021-09326-w","article-title":"Validation and update of a multivariable prediction model for the identification and management of patients at risk for hepatocellular carcinoma","volume":"18","author":"Li","year":"2021","journal-title":"Clin Proteomics"},{"key":"10.1016\/j.jhep.2025.09.023_bib10","article-title":"ASAP Score versus GALAD Score for detection of hepatitis C-related hepatocellular carcinoma: a multicenter case-control analysis","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.jhep.2025.09.023_bib11","first-page":"2588","article-title":"High PIVKA-II level and ASAP score predict 1-year risk of hepatocellular carcinoma in non-cirrhotic chronic hepatitis B patients","volume":"13","author":"Lu","year":"2023","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.jhep.2025.09.023_bib12","article-title":"Validation of the updated hepatocellular carcinoma early detection screening algorithm in a community-based cohort of patients with cirrhosis of multiple etiologies","author":"Tayob","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.jhep.2025.09.023_bib13","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/j.cgh.2018.12.005","article-title":"Validation of the hepatocellular carcinoma early detection screening (HES) algorithm in a cohort of veterans with cirrhosis","volume":"17","author":"Tayob","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2025.09.023_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12874-017-0458-6","article-title":"Evaluating screening approaches for hepatocellular carcinoma in a cohort of HCV related cirrhosis patients from the Veteran's Affairs Health Care System","volume":"18","author":"Tayob","year":"2018","journal-title":"BMC Med Res Methodol"},{"issue":"7","key":"10.1016\/j.jhep.2025.09.023_bib15","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1053\/j.gastro.2015.10.004","article-title":"The updated model: an adjusted serum alpha-fetoprotein-based algorithm for hepatocellular carcinoma detection with hepatitis C virus-related cirrhosis","volume":"149","author":"White","year":"2015","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.jhep.2025.09.023_bib16","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1053\/j.gastro.2014.01.045","article-title":"A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis","volume":"146","author":"El-Serag","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.09.023_bib17","article-title":"HES V2.0 outperforms GALAD for detection of HCC: a phase 3 biomarker study in the United States","author":"El-Serag","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.09.023_bib18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cct.2018.11.008","article-title":"Rationale and design of the hepatocellular carcinoma early detection Strategy study: a multi-center longitudinal initiative of the national cancer institute's early detection research Network","volume":"76","author":"Borges","year":"2019","journal-title":"Contemp Clin Trials"},{"issue":"2","key":"10.1016\/j.jhep.2025.09.023_bib19","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American association for the study of liver diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"issue":"20","key":"10.1016\/j.jhep.2025.09.023_bib20","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/jnci\/djn326","article-title":"Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design","volume":"100","author":"Pepe","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"14","key":"10.1016\/j.jhep.2025.09.023_bib21","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/jnci\/93.14.1054","article-title":"Phases of biomarker development for early detection of cancer","volume":"93","author":"Pepe","year":"2001","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"10.1016\/j.jhep.2025.09.023_bib22","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1373\/clinchem.2011.164657","article-title":"Improving biomarker identification with better designs and reporting","volume":"57","author":"Pepe","year":"2011","journal-title":"Clin Chem"},{"issue":"7","key":"10.1016\/j.jhep.2025.09.023_bib23","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1053\/j.gastro.2021.01.233","article-title":"International liver cancer association (ILCA) white paper on biomarker development for hepatocellular carcinoma","volume":"160","author":"Singal","year":"2021","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.jhep.2025.09.023_bib24","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.cgh.2015.12.042","article-title":"Role of the GALAD and BALAD-2 serologic models in diagnosis of hepatocellular carcinoma and prediction of survival in patients","volume":"14","author":"Berhane","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jhep.2025.09.023_bib25","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3390\/jcm12030949","article-title":"The performance of GALAD score for diagnosing hepatocellular carcinoma in patients with chronic liver diseases: a systematic review and meta-analysis","volume":"12","author":"Guan","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.jhep.2025.09.023_bib26","article-title":"Bootstrap methods and their application","volume":"94","author":"Davison","year":"1997","journal-title":"J Am Stat Assoc"},{"issue":"1","key":"10.1016\/j.jhep.2025.09.023_bib27","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2009.04.005","article-title":"Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma","volume":"137","author":"Marrero","year":"2009","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.jhep.2025.09.023_bib28","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1053\/j.gastro.2018.01.064","article-title":"Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis","volume":"154","author":"Tzartzeva","year":"2018","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jhep.2025.09.023_bib29","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1158\/1055-9965.EPI-18-0281","article-title":"GALAD score for hepatocellular carcinoma detection in comparison with liver ultrasound and proposal of GALADUS score","volume":"28","author":"Yang","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"10.1016\/j.jhep.2025.09.023_bib30","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.cgh.2023.07.018","article-title":"Financial burden of hepatocellular carcinoma screening in patients with cirrhosis","volume":"22","author":"Narasimman","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2025.09.023_bib31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/HEP.0000000000000528","article-title":"Hepatocellular carcinoma surveillance may be associated with potential psychological harms in patients with cirrhosis","volume":"79","author":"Narasimman","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.09.023_bib32","article-title":"Benefits and harms of hepatocellular carcinoma surveillance in a prospective cohort of patients with cirrhosis","author":"Singal","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2025.09.023_bib33","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s11901-019-00488-8","article-title":"Harms of hepatocellular carcinoma surveillance","volume":"18","author":"Petrasek","year":"2019","journal-title":"Curr Hepatol Rep"},{"key":"10.1016\/j.jhep.2025.09.023_bib34","article-title":"Value of HCC surveillance in a landscape of emerging surveillance options: perspectives of a multi-stakeholder modified delphi panel","author":"Singal","year":"2024","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jhep.2025.09.023_bib35","doi-asserted-by":"crossref","DOI":"10.1080\/20450923.2025.2494446","article-title":"HES V2.0 surpasses GALAD for HCC detection: a review of multi-dimensional biomarker scores and studies","volume":"12","author":"Jaber","year":"2025","journal-title":"Hepat Oncol"},{"issue":"11","key":"10.1016\/j.jhep.2025.09.023_bib36","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000565","article-title":"National liver cancer screening trial (TRACER) study protocol","volume":"8","author":"Singal","year":"2024","journal-title":"Hepatol Commun"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827825025188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827825025188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:57:53Z","timestamp":1777528673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827825025188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0168827825025188"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2025.09.023","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HES V2.0 validation and performance compared to GALAD and ASAP in the HEDS cohort","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2025.09.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Association for the Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}